P2B-001 combines a dopamine agonist (pramipexole) and a MAO-B inhibitor (rasagiline) in a small molecule formulation. It targets motor impairment by both stimulating dopamine receptors and preventing dopamine breakdown, thus enhancing dopamine availability.
Discover our Products
Science-based supplements that work synergistically
Sign Up to our Newsletter to get notified when the YuthLabs Red and Infrared Light Cap is live!
Subscribe & Join Our Pre-Order Waitlist
